Published in N Engl J Med on July 30, 1987
Interaction between arrival time and thrombolytic treatment in determining early outcome of acute myocardial infarction. Heart (2002) 0.82
Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation. Am J Cardiol (2008) 0.80
Predictors of early ventricular fibrillation before reperfusion therapy for acute ST-elevation myocardial infarction. Neth Heart J (2004) 0.75
Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction. J Geriatr Cardiol (2016) 0.75
Dysrhythmias in acute myocardial infarction: how to treat, when to treat, and when not to treat. Tex Heart Inst J (1992) 0.75
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med (2001) 20.20
Raman spectrum of graphene and graphene layers. Phys Rev Lett (2006) 16.04
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med (2001) 9.75
Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med (2001) 8.74
A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med (1995) 7.88
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging (2005) 4.88
The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care (2001) 3.67
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Health services: an Italian market. Lancet (1996) 3.43
Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. Br J Psychiatry (1999) 2.50
The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med (1997) 2.41
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. Chest (1994) 2.32
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
The EMIP project. European Myocardial Infarction Project. Eur Heart J (2000) 2.15
The teaching and organisation of clinical pharmacology in European medical schools (W.H.O. Working Group on Clinical Pharmacology). Eur J Clin Pharmacol (1990) 2.07
Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ (2014) 2.06
Has clinical pharmacology lost its way? Lancet (1984) 2.02
Clinical pharmacokinetics of diazepam. Clin Pharmacokinet (1978) 1.99
Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol (1977) 1.94
The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J (2000) 1.90
"Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet (1984) 1.87
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med (1993) 1.81
ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation (1995) 1.75
North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet (1998) 1.75
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation (1993) 1.74
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation (1997) 1.68
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Feasibility of a large prospective study in general practice: an Italian experience. Gruppo di Studio sulla Pressione Arteriosa nell'Anziano. Br Med J (Clin Res Ed) (1987) 1.65
Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol (1982) 1.64
Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Br J Clin Pharmacol (1975) 1.63
Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med (2005) 1.59
Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures. GISSI-Prognosis Investigators. Eur Heart J (1998) 1.56
Risk factors for myocardial infarction in young women. Am J Epidemiol (1987) 1.55
A randomized comparison of Burch colposuspension and abdominal paravaginal defect repair for female stress urinary incontinence. Am J Obstet Gynecol (1996) 1.54
N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia (1975) 1.54
Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet (1984) 1.53
Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51
Second-generation clinical pharmacology. Lancet (1986) 1.49
The long-term prognostic significance of repeated blood pressure measurements in the elderly: SPAA (Studio sulla Pressione Arteriosa nell'Anziano) 10-year follow-up. Arch Intern Med (1999) 1.48
Persistent tardive dyskinesia: demographic and pharmacological risk factors. Acta Psychiatr Scand (1993) 1.48
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis (1983) 1.47
A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Dis (2001) 1.45
The origin of brain metastases in patients with an undiagnosed primary tumour. Acta Neurochir (Wien) (2004) 1.44
Trends in perinatal, neonatal and postneonatal mortality in Italy, 1955-84. Soz Praventivmed (1987) 1.41
Antibiotic treatments of a methicillin-resistant Staphylococcus pseudintermedius infection in a dog: a case presentation. Schweiz Arch Tierheilkd (2011) 1.39
Caffeine disposition after oral doses. Clin Pharmacol Ther (1982) 1.39
Benzodiazepines: clinical pharmacology and therapeutic use. Drugs (1980) 1.36
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J (1999) 1.36
Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol (1993) 1.34
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study. Am J Cardiol (1998) 1.31
Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe. Eur J Clin Pharmacol (1990) 1.30
Information on drug use in pregnancy from the Viewpoint Regional Drug Information Centre. Eur J Clin Pharmacol (1988) 1.28
230 patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg (1994) 1.27
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland. Support Care Cancer (1996) 1.23
Internet for clinical trials: past, present, and future. Control Clin Trials (1999) 1.21
Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med (1987) 1.20
Molecular and genomic analysis of genes encoding surface-anchored proteins from Clostridium difficile. Infect Immun (2001) 1.20
Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators. Circulation (1992) 1.20
Lung changes in rheumatoid arthritis: CT findings. Radiology (1994) 1.19
Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials. Psychol Med (1994) 1.19
Risk factors for endometrial cancer at different ages. J Natl Cancer Inst (1984) 1.18
Tar yield of cigarettes and risk of acute myocardial infarction. GISSI-EFRIM Investigators. BMJ (1993) 1.17
The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes. Diabetes Care (2001) 1.17
Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol (1989) 1.16
p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer. Eur J Cancer (2000) 1.15
A new 2D-based method for myocardial velocity strain and strain rate quantification in a normal adult and paediatric population: assessment of reference values. Cardiovasc Ultrasound (2009) 1.15
Diazepam elimination in premature and full term infants, and children. J Perinat Med (1973) 1.15
Management of recurrent cervical cancer: a review of the literature. Surg Oncol (2012) 1.14
Monoclonal antibodies for rapid diagnosis and typing of genital herpes infections during pregnancy. Am J Obstet Gynecol (1983) 1.14
A model to control data flow in multicenter clinical trials. Methods Inf Med (1995) 1.13
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate? Ann Oncol (1993) 1.12
Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol (1990) 1.11